(Q51589013)
Statements
1 reference
Axitinib Versus Sorafenib in First-Line Metastatic Renal Cell Carcinoma: Overall Survival From a Randomized Phase III Trial. (English)
1 reference
Thomas E Hutson
Salman Al-Shukri
Oleg N Lipatov
Yaroslav Shparyk
Angel H Bair
Brad Rosbrook
Glen I Andrews
Nicholas J Vogelzang
27 May 2016
1 reference